SAB Biotherapeutics | Results Presentation Deck

Includes exhibit number and presenter credentials.

Slide schematic 4/4

image 1/1 other 1/1 paragraph 1/1 title 1/1

Components 4

logo unclassified paragraph headline

Tools 1

title/headline: Efficacy and Safety of SAB-176, a Novel Anti-Type A and B Influenza Immunotherapeutic: A Phase 2a, Randomized, Double-Blind Trial in H1N1 Challenged Adults

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.